Skip to main content
. 2009 Apr 7;7:4. doi: 10.1186/1478-7547-7-4

Table 11.

Test 4: Sensitivity Analysis Olanzapine Versus Risperidone: Changing CATIE Relapse Risk Ratios to Achieve Desired ICER Result

ICER
RIS/OLZ Ratio OLZ RIS
1.55 (Base Case)* Dominant -
1.54 Cost-Neutral
0.70 Effectiveness-Neutral

*Base case ratio from CATIE Phase 1 [23] which reported hospitalization risk ratios normalized to 1 person year of exposure: RIS = 0.45, OLZ = 0.29, and RIS/OLZ = 1.55.

ICER = incremental cost-effectiveness ratio; RIS = risperidone; OLZ = olanzapine